Modus Therapeutics Secures Bridge Financing From Karolinska Development

March 29 (Reuters) - Modus Therapeutics Holding AB :

* MODUS THERAPEUTICS SECURES ACCESS TO BRIDGE FINANCING FROM LONGSTANDING INVESTOR KAROLINSKA DEVELOPMENT

* ACCESS TO THIS FUNDING ENSURES THAT MOMENTUM OF CLINICAL DEVELOPMENT OF SEVUPARIN WILL BE ENHANCED

* FUTURE DEVELOPMENT PLANS INCLUDE PREPARATION FOR A PHASE 2A STUDY EVALUATING SEVUPARIN FOR TREATMENT OF SEPSIS, EXPECTED TO COMMENCE AT END OF 2023 Source text for Eikon: Further company coverage: (Gdansk Newsroom)